From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer
Response
No. of Patients
Percentage
Median Duration of Response (range)
Partial
11
55%
6 months (1.5 – 20)
Stable
7
35%
4.5 (2 – 6)
Progressive
2
10%
N/A